(December 2009)
ISSN 0007-0920
Welcome to BJC
Multidisciplinary Journal of Cancer Research
BJC publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients.
BJC is proud of its editorial independence, high standards, and tradition of serving the international cancer research community - we are one of the world's leading general cancer journals.
Impact factor 4.846
- one of the Top 10 Cancer titles with the highest number of overall citations
2008 Journal Citation Reports (Thomson Reuters, 2009)
Web Focus on Human Papillomavirus (HPV)
It is now well established that infection with 'high risk' strains of human papillomavirus (HPV) significantly increases risk of developing cervical cancer. Strains 16 and 18 alone are implicated in ~70% of cervical cancer cases. Recent advances in HPV screening methods and the availability of vaccination have made HPV a "Hot topic" in both research and the media; this web focus brings together a selection of key articles recently published by BJC in this field.
Click here to view the BJC Web Focus on Human Papillomavirus (HPV)
Trends and inequalities in survival for 20 cancers in England and Wales 1986-2001: population-based analyses and clinical commentaries
This Cancer Research UK supplement provides important new information and commentary on survival rates for the 20 most common cancers diagnosed in England and Wales over a 14-year period from 1986 to 1999. The analyses are based on data collected by cancer registries on 2.2 million cancer patients. The authors have assessed both trends in survival rates over time and inequalities in survival between groups of patients with different levels of deprivation. The unique pairing of epidemiology and expert clinical analysis should provide a complete picture of the state of cancer survival and cancer care in England and Wales.
Click here to view the supplement.
Archive
Coinciding with the release of the first issue of Volume 99 of BJC on 1st July 2008, and the launch of our new website design, BJC, NPG and Cancer Research UK are pleased to announce that all BJC papers will become freely available to readers of this website, 12 months after they are published.
This applies in the first instance to papers published in and after 1999. Please see our Archive page for the details.
Featured Articles
-
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy FREE
-
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients FREE
-
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer FREE
-
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways FREE
-
A prospective study of lifetime physical activity and prostate cancer incidence and mortality FREE
-
Geographical and temporal distribution of cancer survival in teenagers and young adults in England FREE
-
Preclinical mouse models for BRCA1-associated breast cancer FREE
-
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
-
Activation and clinical significance of the unfolded protein response in breast cancer
-
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
-
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors FREE
-
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
-
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
-
Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas
-
